The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial

NCT03158935 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Advanced Ovarian Cancer
Malignant Melanoma

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Pembrolizumab
BIOLOGICAL: Tumor-Infiltrating Lymphocytes (TILs)
BIOLOGICAL: Interleukin-2 (IL-2)

Sponsor

University Health Network, Toronto

Collaborators

[object Object]